Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
Astrazeneca (AZN) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Friday, 19'th Jan 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GSK and AstraZeneca: A leading investment bank gives its verdict with an upgrade and a downgrade
12:02pm, Tuesday, 16'th Jan 2024
UBS has revised its stance on two major UK-listed pharma companies - GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) - with an upgrade for the former and a downgrade for the latter. GSK i
AstraZeneca, LSE and Heathrow among 320 co's to make nature-based disclosures in financial results
08:26am, Tuesday, 16'th Jan 2024
Over 300 companies, including AstraZeneca, Anglo American, Endeavour Mining, Heathrow Airport and British American Tobacco, will start to include nature-related disclosures as part of their annual c
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK
05:34am, Tuesday, 16'th Jan 2024
UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of AstraZeneca and a double-upgrade of U.K. rival GSK.
AstraZeneca says no supply snags so far from Red Sea disruptions
12:37pm, Monday, 15'th Jan 2024
Drugmaker AstraZeneca has not seen any supply issues so far due to Red Sea shipping disruptions, a top executive told Reuters ahead of the World Economic Forum (WEF) on Monday.
AstraZeneca: Leading bank bullish after key conference appearance
06:09am, Monday, 15'th Jan 2024
JP Morgan has maintained its bullish stance on AstraZeneca PLC (LSE:AZN) in the wake of the San Francisco healthcare conference it sponsors. Repeating its overweight stance £130 a share price target
Astrazeneca (AZN) Laps the Stock Market: Here's Why
07:34pm, Friday, 12'th Jan 2024
In the latest trading session, Astrazeneca (AZN) closed at $69.42, marking a +0.35% move from the previous day.
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
09:02am, Friday, 12'th Jan 2024
The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases and is gaining significant popularity.
White House says officials met with Sanofi, AstraZeneca on RSV immunization
10:02pm, Thursday, 11'th Jan 2024
Senior U.S. officials met this week with the manufacturers of RSV immunizations for infants, pushing companies including Sanofi and AstraZeneca to continue efforts to meet demand, the White House said
Here's Why Astrazeneca (AZN) Fell More Than Broader Market
07:33pm, Thursday, 11'th Jan 2024
Astrazeneca (AZN) closed at $69.18 in the latest trading session, marking a -0.56% move from the prior day.
AstraZeneca: Rebound in 2024 with double-digit earnings growth
06:20am, Thursday, 11'th Jan 2024
U.K.-based AstraZeneca PLC NASDAQ: AZN is up 8.95% in the past month as investors grow optimistic about the company's improved earnings outlook for 2024. Not only are sales of cancer and diabetes drug
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
07:33pm, Tuesday, 09'th Jan 2024
Astrazeneca (AZN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
International Wide-Moat Stocks On Sale - The January 2024 Heat Map
06:04pm, Tuesday, 09'th Jan 2024
International Wide-Moat Stocks On Sale - The January 2024 Heat Map
Are defensive sectors ready to outshine growth in 2024?
07:50am, Saturday, 06'th Jan 2024
The Health Care Select Sector SPDR Fund NYSEARCA: XLV, which has both growth and defensive characteristics, was the leader in the first week of the year. Top sector performers included Moderna Inc. NA
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
07:34pm, Friday, 05'th Jan 2024
The latest trading day saw Astrazeneca (AZN) settling at $68.38, representing a -0.58% change from its previous close.
